2 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Toxemia: new trials by email Literature Review of Toxemia trials Research Report on Toxemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis human lactoferrin peptide 1-11 - Staphylococcal Infections, Bacteremia | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2009-02-01 | 2014-05-28 | |
| Treatment Targets for Chronic Hypertension in Pregnancy methyldopa, labetalol, nifedipine - Pregnancy Toxemia, Hypertension | Phase 1 / Phase 2 | Withdrawn | Weill Medical College of Cornell University | 2004-07-01 | 2017-01-30 |
Bacteremia (1) · Hypertension (1) · Pre-Eclampsia (1) · Proteinuria (1) · Staphylococcal Infections (1)
Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gram-Positive Bacterial Infections (1) · Hypertension, Pregnancy-Induced (1) · Inflammation (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pregnancy Complications (1) · Sepsis (1) · Signs and Symptoms (1)
Clonidine (1) · Labetalol (1) · Methyldopa (1) · Nifedipine (1) · lactoferrin (1-11), human (1)
AM-Pharma (1) · Weill Medical College of Cornell University (1)
Netherlands (1) · United States (1)
Phyllis August, MD MPH (1) · Professor P.E. Verweij, MD, PhD (1)